177Lu-PSMA-617 for metastatic prostate cancer in India

被引：2

作者：

Ghose, Aruni ^{[1
,2
,3
,4
,5
,6
]}

Banerjee, Soirindhri ^{[7
]}

Choudhury, Partha S. ^{[8
]}

Maniam, Akash ^{[9
,10
]}

Gupta, Manoj ^{[8
]}

Banna, Giuseppe L. ^{[9
,11
]}

Vasdev, Nikhil ^{[4
,12
,13
]}

Ghose, Amit ^{[14
]}

Noronha, Vanita ^{[15
]}

Mitra, Swarupa ^{[16
]}

机构：

[1] United Kingdom & Ireland Global Canc Network, Manchester, England

[2] Barts Hlth NHS Trust, St Bartholomews Hosp, Barts Canc Ctr, London, England

[3] Queen Mary Univ London, Barts Canc Inst, Ctr Canc Biomarkers & Biotherapeut, London, England

[4] East & North Hertfordshire NHS Trust, Lister Hosp, Hertfordshire & Bedfordshire Urol Canc Ctr, Stevenage, England

[5] Medway NHS Fdn Trust, Dept Oncol, Gillingham, England

[6] European Canc Org, Inequal Network, Brussels, Belgium

[7] IPGMER & SSKM Hosp, Dept Radiat Oncol, Kolkata, India

[8] Rajiv Gandhi Canc Inst & Res Ctr, Delhi, India

[9] Portsmouth Hosp Univ NHS Trust, Dept Med Oncol, Portsmouth, England

[10] Caribbean Canc Res Inst, Port Of Spain, Trinidad Tobago

[11] Univ Portsmouth, Fac Sci & Hlth, Sch Pharm & Biomed Sci, Portsmouth, England

[12] Univ Hertfordshire, Sch Life & Med Sci, Hatfield, England

[13] Apollo Hosp Educ & Res Fdn, Hyderabad, India

[14] Apollo Multispecial Hosp, Dept Urol, Kolkata, India

[15] Tata Mem Hosp, Homi Bhabha Natl Inst, Tata Mem Ctr, Dept Med Oncol, Mumbai, India

[16] Fortis Mem Res Inst, Fortis Canc Inst, Gurugram, India

来源：

LANCET REGIONAL HEALTH - SOUTHEAST ASIA | 2024年 / 30卷

关键词：

D O I：

10.1016/j.lansea.2024.100484

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

引用

页数：3

共 13 条

[1] Theranostics in India: a Particularly Exquisite Concept or an Experimental Tool [J].

Choudhury, Partha S. ;

Gupta, Manoj .

NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 53 (02) :92-95

[2]

Choudhury PS, 2022, The evolution of radionanotargeting towards clinical precision oncology: a festschrift in honor of kalevi kairemo, P246

[3] Clinical translation of 177Lu-labeled PSMA-617: Initial experience in prostate cancer patients [J].

Das, Tapas ;

Guleria, Mohini ;

Parab, Anil ;

Kale, Chanchala ;

Shah, Hina ;

Sarma, Haladhar D. ;

Lele, Vikram R. ;

Banerjee, Sharmila .

NUCLEAR MEDICINE AND BIOLOGY, 2016, 43 (05) :296-302

[4] Preparation of Therapeutic Dose of Lu-177-DOTA-TATE Using a Novel Single Vial Freeze-dried Kit: A Comparison with 'In-situ' Preparation at Hospital Radiopharmacy [J].

Das, Tapas ;

Banerjee, Sharmila ;

Shinto, Ajit ;

Kamaleshwaran, K. K. ;

Sarma, H. D. .

CURRENT RADIOPHARMACEUTICALS, 2014, 7 (01) :12-19

[5] FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer [J].

Fallah, Jaleh ;

Agrawal, Sundeep ;

Gittleman, Haley ;

Fiero, Mallorie H. ;

Subramaniam, Sriram ;

John, Christy ;

Chen, Wei ;

Ricks, Tiffany K. ;

Niu, Gang ;

Fotenos, Anthony ;

Wang, Min ;

Chiang, Kelly ;

Pierce, William F. ;

Suzman, Daniel L. ;

Tang, Shenghui ;

Pazdur, Richard ;

Amiri-Kordestani, Laleh ;

Ibrahim, Amna ;

Kluetz, Paul G. .

CLINICAL CANCER RESEARCH, 2023, 29 (09) :1651-1657

[6]

Ghose Amit, 2020, [The Korean Journal of Urological Oncology, 대한비뇨기종양학술지], V18, P170, DOI 10.22465/kjuo.2020.18.3.170

[7] Genetic Aberrations of DNA Repair Pathways in Prostate Cancer: Translation to the Clinic [J].

Ghose, Aruni ;

Moschetta, Michele ;

Pappas-Gogos, George ;

Sheriff, Matin ;

Boussios, Stergios .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)

[8] [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial [J].

Hofman, Michael S. ;

Emmett, Louise ;

Sandhu, Shahneen ;

Iravani, Amir ;

Joshua, Anthony M. ;

Goh, Jeffrey C. ;

Pattison, David A. ;

Tan, Thean Hsiang ;

Kirkwood, Ian D. ;

Ng, Siobhan ;

Francis, Roslyn J. ;

Gedye, Craig ;

Rutherford, Natalie K. ;

Weickhardt, Andrew ;

Scott, Andrew M. ;

Lee, Sze-Ting ;

Kwan, Edmond M. ;

Azad, Arun A. ;

Ramdave, Shakher ;

Redfern, Andrew D. ;

Macdonald, William ;

Guminski, Alex ;

Hsiao, Edward ;

Chua, Wei ;

Lin, Peter ;

Zhang, Alison Y. ;

McJannett, Margaret M. ;

Stockler, Martin R. ;

Violet, John A. ;

Williams, Scott G. ;

Martin, Andrew J. ;

Davis, Ian D. .

LANCET, 2021, 397 (10276) :797-804

[9] Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer [J].

Kanesvaran, R. ;

Castro, E. ;

Wong, A. ;

Fizazi, K. ;

Chua, M. L. K. ;

Zhu, Y. ;

Malhotra, H. ;

Miura, Y. ;

Lee, J. L. ;

Chong, F. L. T. ;

Pu, Y-S ;

Yen, C-C ;

Saad, M. ;

Lee, H. J. ;

Kitamura, H. ;

Prabhash, K. ;

Zou, Q. ;

Curigliano, G. ;

Poon, E. ;

Choo, S. P. ;

Peters, S. ;

Lim, E. ;

Yoshino, T. ;

Pentheroudakis, G. .

ESMO OPEN, 2022, 7 (04)

[10] The Urological Society of India guidelines for the evaluation and management of prostate cancer (executive summary) [J].

Kumar, Anup ;

Yadav, Siddharth ;

Krishnappa, Raghunath S. ;

Gautam, Gagan ;

Raghavan, Narasimhan ;

Bakshi, Ganesh ;

Prakash, Gagan ;

Ahluwalia, Puneet ;

Tamankar, Ashwin ;

Surekha, Sanjoy ;

Kumar, Niraj ;

Kumar, Sandeep ;

Mallya, Ashwin ;

Saini, Gagan ;

Singhal, Manish ;

Mavuduru, Ravimohan ;

Nayak, Brusabhanu ;

Singh, Prabhjot ;

Jaipuria, Jiten ;

Kumar, Vijoy ;

Rawal, Sudhir K. ;

Gupta, Narmada Prasad .

INDIAN JOURNAL OF UROLOGY, 2022, 38 (04) :252-257

← 1 2 →